Review



anti senescence marker protein 30  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Proteintech anti senescence marker protein 30
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Anti Senescence Marker Protein 30, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti senescence marker protein 30/product/Proteintech
    Average 94 stars, based on 19 article reviews
    anti senescence marker protein 30 - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "NMNAT1 Activates Autophagy to Delay D‐Galactose‐Induced Aging in Cochlear Hair Cells"

    Article Title: NMNAT1 Activates Autophagy to Delay D‐Galactose‐Induced Aging in Cochlear Hair Cells

    Journal: Aging Cell

    doi: 10.1111/acel.70373

    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Figure Legend Snippet: Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Techniques Used: CCK-8 Assay, Staining, Flow Cytometry, Western Blot, Marker, Expressing

    Establishment of D‐gal‐induced aging model in cochlear explants. (A) Immunofluorescence staining demonstrating the number of myosin7a + hair cells in cochlear explants treated with 20, 30, and 40 mg/mL D‐gal for 72 h. (B) Quantification of the number of myosin7a + hair cells in cochlear explants ( n = 4; four individual explants from four mice). (C–E) Western blotting of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X expression in cochlear explants exposed to D‐gal. (F–H) Statistical analysis of SMP30 ( n = 5), Lamin B1 ( n = 3), and γ‐H2A.X ( n = 3) in C–E; n corresponds to the number of independent samples, each consisting of 12 explants from six mice. (I) Senescence‐associated β‐gal staining images of hair cells in cochlear explants exposed to D‐gal. (J) Quantification of β‐gal staining intensity in I ( n = 4; four individual explants from four mice). Scale bar: 20 μm. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Figure Legend Snippet: Establishment of D‐gal‐induced aging model in cochlear explants. (A) Immunofluorescence staining demonstrating the number of myosin7a + hair cells in cochlear explants treated with 20, 30, and 40 mg/mL D‐gal for 72 h. (B) Quantification of the number of myosin7a + hair cells in cochlear explants ( n = 4; four individual explants from four mice). (C–E) Western blotting of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X expression in cochlear explants exposed to D‐gal. (F–H) Statistical analysis of SMP30 ( n = 5), Lamin B1 ( n = 3), and γ‐H2A.X ( n = 3) in C–E; n corresponds to the number of independent samples, each consisting of 12 explants from six mice. (I) Senescence‐associated β‐gal staining images of hair cells in cochlear explants exposed to D‐gal. (J) Quantification of β‐gal staining intensity in I ( n = 4; four individual explants from four mice). Scale bar: 20 μm. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Techniques Used: Immunofluorescence, Staining, Western Blot, Marker, Expressing



    Similar Products

    anti senescence marker protein 30  (Proteintech)
    94
    Proteintech anti senescence marker protein 30
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Anti Senescence Marker Protein 30, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti senescence marker protein 30/product/Proteintech
    Average 94 stars, based on 1 article reviews
    anti senescence marker protein 30 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    17947 1 ap  (Proteintech)
    94
    Proteintech 17947 1 ap
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    17947 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/17947 1 ap/product/Proteintech
    Average 94 stars, based on 1 article reviews
    17947 1 ap - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    smp30  (Proteintech)
    94
    Proteintech smp30
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Smp30, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/smp30/product/Proteintech
    Average 94 stars, based on 1 article reviews
    smp30 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    rgn smp30  (Proteintech)
    94
    Proteintech rgn smp30
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Rgn Smp30, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rgn smp30/product/Proteintech
    Average 94 stars, based on 1 article reviews
    rgn smp30 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    rgn  (Proteintech)
    94
    Proteintech rgn
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Rgn, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rgn/product/Proteintech
    Average 94 stars, based on 1 article reviews
    rgn - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    anti lamin b1 polyclonal  (Proteintech)
    94
    Proteintech anti lamin b1 polyclonal
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Anti Lamin B1 Polyclonal, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti lamin b1 polyclonal/product/Proteintech
    Average 94 stars, based on 1 article reviews
    anti lamin b1 polyclonal - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    anti rgn  (Proteintech)
    94
    Proteintech anti rgn
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Anti Rgn, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rgn/product/Proteintech
    Average 94 stars, based on 1 article reviews
    anti rgn - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    anti smp30  (Proteintech)
    94
    Proteintech anti smp30
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Anti Smp30, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti smp30/product/Proteintech
    Average 94 stars, based on 1 article reviews
    anti smp30 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    anti smp30 antibody  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology anti smp30 antibody
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Anti Smp30 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti smp30 antibody/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    anti smp30 antibody - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Journal: Aging Cell

    Article Title: NMNAT1 Activates Autophagy to Delay D‐Galactose‐Induced Aging in Cochlear Hair Cells

    doi: 10.1111/acel.70373

    Figure Lengend Snippet: Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Article Snippet: The primary antibodies used in this study were as follows: rabbit anti‐β‐tubulin (1:40000, 5568; CST), rabbit anti‐β‐Actin (1:40000, 20536‐1‐AP; Proteintech), mouse anti‐GAPDH (1:4000, ab8245; Abcam), rabbit anti‐senescence marker protein‐30 (SMP30) (1:1000, 17947‐1‐AP; Proteintech), rabbit anti‐lamin B1 (1:1000, 13435; CST), rabbit anti‐γ‐H2A.X (1:400, 2577; CST), rabbit anti‐P21 (1:1000, 37543; CST), rabbit anti‐P16 (1:1000, 29271; CST), rabbit anti‐NMNAT1 (1:1000, 98354; CST), rabbit anti‐NMNAT1 (1:400, 11399‐1‐AP; Proteintech), rabbit anti‐LC3B (1:1000, 3868; CST), rabbit anti‐P62 (1:1000, 23214; CST), mouse anti‐autophagy related 7 (ATG7) (1:1000, 67341; Proteintech), and rabbit anti‐BECLIN1 (1:1000, 3495; CST).

    Techniques: CCK-8 Assay, Staining, Flow Cytometry, Western Blot, Marker, Expressing

    Establishment of D‐gal‐induced aging model in cochlear explants. (A) Immunofluorescence staining demonstrating the number of myosin7a + hair cells in cochlear explants treated with 20, 30, and 40 mg/mL D‐gal for 72 h. (B) Quantification of the number of myosin7a + hair cells in cochlear explants ( n = 4; four individual explants from four mice). (C–E) Western blotting of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X expression in cochlear explants exposed to D‐gal. (F–H) Statistical analysis of SMP30 ( n = 5), Lamin B1 ( n = 3), and γ‐H2A.X ( n = 3) in C–E; n corresponds to the number of independent samples, each consisting of 12 explants from six mice. (I) Senescence‐associated β‐gal staining images of hair cells in cochlear explants exposed to D‐gal. (J) Quantification of β‐gal staining intensity in I ( n = 4; four individual explants from four mice). Scale bar: 20 μm. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Journal: Aging Cell

    Article Title: NMNAT1 Activates Autophagy to Delay D‐Galactose‐Induced Aging in Cochlear Hair Cells

    doi: 10.1111/acel.70373

    Figure Lengend Snippet: Establishment of D‐gal‐induced aging model in cochlear explants. (A) Immunofluorescence staining demonstrating the number of myosin7a + hair cells in cochlear explants treated with 20, 30, and 40 mg/mL D‐gal for 72 h. (B) Quantification of the number of myosin7a + hair cells in cochlear explants ( n = 4; four individual explants from four mice). (C–E) Western blotting of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X expression in cochlear explants exposed to D‐gal. (F–H) Statistical analysis of SMP30 ( n = 5), Lamin B1 ( n = 3), and γ‐H2A.X ( n = 3) in C–E; n corresponds to the number of independent samples, each consisting of 12 explants from six mice. (I) Senescence‐associated β‐gal staining images of hair cells in cochlear explants exposed to D‐gal. (J) Quantification of β‐gal staining intensity in I ( n = 4; four individual explants from four mice). Scale bar: 20 μm. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Article Snippet: The primary antibodies used in this study were as follows: rabbit anti‐β‐tubulin (1:40000, 5568; CST), rabbit anti‐β‐Actin (1:40000, 20536‐1‐AP; Proteintech), mouse anti‐GAPDH (1:4000, ab8245; Abcam), rabbit anti‐senescence marker protein‐30 (SMP30) (1:1000, 17947‐1‐AP; Proteintech), rabbit anti‐lamin B1 (1:1000, 13435; CST), rabbit anti‐γ‐H2A.X (1:400, 2577; CST), rabbit anti‐P21 (1:1000, 37543; CST), rabbit anti‐P16 (1:1000, 29271; CST), rabbit anti‐NMNAT1 (1:1000, 98354; CST), rabbit anti‐NMNAT1 (1:400, 11399‐1‐AP; Proteintech), rabbit anti‐LC3B (1:1000, 3868; CST), rabbit anti‐P62 (1:1000, 23214; CST), mouse anti‐autophagy related 7 (ATG7) (1:1000, 67341; Proteintech), and rabbit anti‐BECLIN1 (1:1000, 3495; CST).

    Techniques: Immunofluorescence, Staining, Western Blot, Marker, Expressing